Skip to main content
Tuoxin Pharmaceutical Group Co.,Ltd. logo

Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 301089 ISIN · CNE100004YC3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2023-04-04 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 301089

About Tuoxin Pharmaceutical Group Co.,Ltd.

https://www.tuoxinpharm.com

Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.

Recent filings

Filing Released Lang Actions
2023年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement for the "2023 Second Extraordinary General Meeting of Shareholders" of the company. It details the meeting date, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and voting process. There is no financial data or report content, but rather the official announcement of the voting results from a shareholders' meeting. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements (DVA)". The document length is short (2158 characters) and focuses on voting outcomes, not on financial or management reports.
2023-04-04 Chinese
关于子公司拓新药业（三亚）有限公司完成工商注册登记并取得营业执照的公告
Regulatory Filings Classification · 100% confidence The document is an announcement from a company about its subsidiary completing business registration and obtaining a business license. It includes details about the subsidiary's registration, legal representative, capital, and business scope. There is no financial data, no mention of annual or quarterly reports, no audit information, no voting results, no management changes, and no other report types. The document is a regulatory announcement about corporate registration and licensing, which does not fit into financial report categories. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-03-29 Chinese
关于持股5%以上股东减持公司股份累计达到1%的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the reduction of shareholding by a shareholder holding more than 5% of the company's shares. It details the shareholder's cumulative share reduction reaching 1%, including dates, share quantities, and compliance with relevant securities laws. The document does not contain financial statements, management discussion, or detailed financial results. It is a regulatory disclosure about a major shareholder's transaction in the company's shares. This fits the definition of a Major Shareholding Notification (MRQ). The document length is under 5,000 characters and is a direct announcement, not a report publication or certification. Therefore, the correct classification is MRQ with high confidence.
2023-03-29 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report" or "Brief Report on Change of Equity Interest." It details the reduction in shareholding by a significant shareholder (Lukecando Enterprises Limited) in the company 新乡拓新药业股份有限公司, including specifics on share quantities, dates, methods of sale (block trades and centralized bidding), and the shareholder's plans for future shareholding changes. The document references relevant Chinese securities laws and disclosure requirements. It is a formal disclosure of a change in major shareholding, not a general regulatory filing or an announcement of a report publication. The content is focused on shareholding changes and ownership percentages, which aligns with the category for Major Shareholding Notification (MRQ). The document length (5864 characters) and detailed data support it being a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2023-03-29 Chinese
关于持股5%以上股东部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from a company about the release of pledged shares by a shareholder holding more than 5% of the company's shares. It details the number of shares released from pledge, the shareholder involved, and cumulative pledge status. There is no financial report, earnings data, or management discussion. The content fits the category of a Major Shareholding Notification, as it concerns changes in significant share ownership or share pledge status by a major shareholder.
2023-03-29 Chinese
关于持股5%以上股东减持至5%以下暨权益变动的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding a shareholder's reduction of holdings from above 5% to below 5%, detailing the shareholding changes, transaction methods, and compliance with relevant securities laws and regulations. It includes specific shareholding percentages before and after the reduction, dates of transactions, and references to regulatory filings. The document is short (2300 characters) and focuses on notifying the market about a major shareholding change rather than providing financial statements or detailed financial analysis. This fits the definition of a Major Shareholding Notification (MRQ).
2023-03-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.